HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Belker Selected Research

Neoplasms (Cancer)

9/2000A phase I study of the antimetabolite (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731) administered as a twice-weekly infusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Belker Research Topics

Disease

1Neoplasms (Cancer)
09/2000
1Rectal Neoplasms (Rectal Cancer)
09/2000

Drug/Important Bio-Agent (IBA)

1tezacitabine (MDL 101,731)IBA
09/2000
1Pharmaceutical PreparationsIBA
09/2000
1Indicators and Reagents (Reagents)IBA
09/2000